baber/WOPTO huggingface dataset:
Patent AU-6492200-A (AU)
Title: Intraluminal stent graft
Inventor: COLONE WILLIAM M
IPC: A61F2/07
Filed: 2000-07-24
Abstract: An intraluminal device such as a stent graft is formed of a conformable ePTFE tube and preferably a compressed self-expanding stent affixed to the tube. The conformable tube is made by a special process which ensures that the tube is radially deformable up to a predetermined diameter without exceeding the plastic deformation limit of the tube. The stent has a relaxed diameter larger than the diameter of the expandable tube after insertion so that the tube is biased to a cylindrical shape. The process for making the tube involves progressively-dilating a small diameter extruded tube until a desired diameter is achieved. The tube is then contracted on a small diameter mandrel by heating.
Patent AU-6718894-A (AU)
Title: Hippuricase gene
Inventor: CHAN VOON LOONG
IPC: C12N9/14
Filed: 1994-05-13
Abstract: A nucleic acid molecule having a sequence encoding benzoyl-glycine aminohydrolase, commonly known as hippuricase, of Campylobacter jejuni is provided. Methods are disclosed for detecting C. jejuni in a biological sample by determining the presence of hippuricase or a nucleic acid molecule encoding hippuricase in the sample.
Patent AU-6727687-A (AU)
Title: Support for out-of-the-ground cultivation comprising superabsorbant particles and method of production
Inventor: BARON GERARD
IPC: A01G31/00
Filed: 1986-11-25
Abstract: The invention relates to the field of out-of-ground cultivation, and more precisely to a cultivation support comprising superabsorbant particles. According to a preferred embodiment, the support is comprised of an envelope (2) consisting of two sheets (3, 4) of polyethylene welded at their edges. The envelope comprises a layer of superabsorbant particles (8) provided between two sheets of cellulose wadding (9). When using the support, openings are made at regular intervals and cultivation plant-containing lumps of earth are inserted therein, and watering is carried out with nutrient solutions. Application for out-of-ground cultivation.
Patent AU-6759301-A (AU)
Title: Fcc reactor vessel
Inventor: BAKKER ERNST ANTONIUS
IPC: B01J8/24
Filed: 2001-07-10
Abstract: Fluidized catalytic cracking reactor vessel comprising at its upper end means to separate catalyst particles from an effluent of a dilute phase fluidized catalytic cracking reactor riser, which separation means are fluidly connected to the downstream part of the reactor riser, fluidly connected with means to discharge the cleaned reactor riser effluent from the vessel and fluidly connected to means to discharge the separated catalyst to the lower end of the vessel, the vessel further comprising at its lower end means to discharge catalyst from the reactor vessel, wherein (a) between the side wall of the vessel and the separation means a shield is present, resulting in an exterior space between the vessel wall and the shield and an interior space within the shield, wherein the interior space is in open communication with the lower end of the reactor vessel at its lower end and wherein the exterior space and interior space are fluidly connected by means of one or more openings, and (b) means are present to supply a gas poor in coke precursors to the exterior space.
Patent AU-6818094-A (AU)
Title: Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
Inventor: KIM SINIL
IPC: A61K9/133
Filed: 1994-04-22
Abstract: PCT No. PCT/US94/04490 Sec. 371 Date Dec. 21, 1995 Sec. 102(e) Date Dec. 21, 1995 PCT Filed Apr. 22, 1994 PCT Pub. No. WO94/23697 PCT Pub. Date Oct. 27, 1994Liposomes containing cyclodextrin in the encapsulated aqueous phase are useful for encapsulation of biologically active substances, especially those which are hydrophilic. The encapsulated cyclodextrin facilitates a slow, controlled release of pharmacologic compounds from the liposomes. The novel methods of the present invention allow the treatment of a variety of pathophysiological states by administering the cyclodextrin-containing liposomes encapsulating the pharmacologic compounds. The present invention also provides a novel method of extending the half life of a pharmacologic compound in an animal.
Patent AU-6917691-A (AU)
Title: Device for cleaning and emptying pipelines for conveying liquids, in particular for conveying beverages in dispensing installations
Inventor: TILL RUDOLF
IPC: B08B9/04
Filed: 1990-12-21
Abstract: In a device for cleaning and emptying pipelines for conveying liquids, in particular for conveying beverages in dispensing installations, which comprises a slide valve or a rotary slide valve, the cylindrical magazine (9) for the elastic, spherical cleaning bodies (10) and the connecting branches (12) leading to a flexible beverage line (13) to the bar are each mounted directly on top of the valve slide (3, 3'), which is actuated by a suitable drive device, above a corresponding hole in the valve slide. The distance between the threaded connection (14) for the cleaning water feed and the connection (4) for the beverage feed in the lower part of the valve housing (1) is equal to the distance between the two holes (8, 11) in the valve slide (3), so that when the slide (3, 3') is in one end position, during operation the two holes (8, 11) are moved so that they cover the two connecting pieces (4, 14) in the lower part of the valve housing (1), and during cleaning or emptying the connection for the beverage feed is closed and the beverage pipeline (13) leading to the bar is connected with the threaded connection (14) for the cleaning water feed.
Patent AU-6992191-A (AU)
Title: Continuous process for the preparation of tetraphosphorus polysulphides
IPC: C01B25/14
Filed: 1991-01-23
Abstract: The invention concerns a continuous procedure for the preparation of tetraphosphorus polysulphides. 
<??>This method consists in carrying out the reaction in a loop reactor. 
<??>It is particularly suitable for the preparation of tetraphosphorus decasulphide P4S10.
Patent AU-7008587-A (AU)
Title: Diphenyl-methane derivatives and pharmaceutical use
Inventor: YAMAGISHI YOUJI
IPC: A61K31/165
Filed: 1987-03-17
Abstract: Diphenyl-methane derivs. of formula (I) are new, (where R1 and R2 each = H, OH or lower alkoxy; U = -CXY or =N-O-W; X = H, CN or -COR6; R6 = OH or NH2; Y = -R10-COOR3, -CONR4R5, -CH2NHSO2-C6H5 or -C(R8)=NR7; R3 = H or lower alkoxy; R10 = opt. branched 1-3C alkylene; R4 and R5 each = H, lower alkyl or lower arylalkyl; R7 = lower alkoxy or aryl; R8 = -VR9; V = O, S or N; R9 = alkyl or aryl; W = -CH2-CO-CH2-COOR13, -CH2-C(=NOR14)-CH2-COOR15, -CH(CN)-(CH2)q-COOR16 or -(CH2)p-Z; R13 = H or lower alkyl; R14 = lower alkyl; R15 = H or lower alkyl; R16 = H or lower alkyl; q = 1-3; Z = -SH, -SCN or a monovalent gp. derived from a 5- or 6-membered ring opt. substd. by a ring with 1 or more S in the ring; p = 1 or 2.
Patent AU-7043296-A (AU)
Title: Apparatus and method for controlling molecular cluster in fluid
Inventor: IBBOTT JACK KENNETH
IPC: C02F1/48
Filed: 1996-10-28
Abstract: An apparatus provides for controlling molecular clusters in fluid in which an electric or a magnetic energy field is applied to a fluid transversely to the flow direction thereof passing through a pipe means. The width of the energy field parallel to the direction of the fluid flow is less than 1 millimeter. The energy field may be applied by two electrodes or two magnetic ploes in which the overall thickness of the electrodes or magnetic poles is less than 10 millimeters. The electrodes or magnetic poles are preferably provided on the outer peripheral surface of the pipe means.
Patent AU-7110796-A (AU)
Title: Borate storage buffer and sample diluent
Inventor: ALTER STEPHEN C
IPC: G01N27/447
Filed: 1996-09-16
Abstract: A composition, which has utility as a storage buffer and as a sample diluent before analysis by capillary zone electrophoresis (CZE), is comprised of water, a borate compound, a buffer compound and a pH modifier for maintaining a physiological pH. In addition, a conductivity adjusting compound is present so that the conductivity of the composition is about the same as a prospective capillary electrophoresis running buffer. Containers with storage buffer/sample diluent can be assembled in a kit for conducting serum protein electrophoresis (SPE) or immunosubtraction (IFE/s) analysis. Moreover, the storage buffer/sample diluent can be used in methods of preparing samples for CZE analysis, such as quantitative dilutions and enzymatic or immunological reactions.\!
Patent AU-7141494-A (AU)
Title: Monitoring multiple amplification reactions simultaneously and analyzing same
Inventor: HIGUCHI RUSSELL G
IPC: C12Q1/68
Filed: 1994-08-23
Abstract: An apparatus for monitoring multiple nucleic acid amplifications simultaneously. In order to provide real-time monitoring of the amplification product of multiple nucleic acid amplifications simultaneously the apparatus is characterized in that it comprises a thermal cycler (12) including a heat conducting member having multiple recesses formed therein; and a sensor (16a) arranged for detecting light emitted from said recesses, simultaneously. <IMAGE>
Patent AU-7153491-A (AU)
Title: Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof
Inventor: THOMASON ARLEN READ
IPC: C12N15/09
Filed: 1990-12-17
Abstract: Novel platelet-derived growth factor (PDGF) analogs are provided in accordance with the present invention. Also provided is a method for the production of homogeneous quantities of these novel analogs. The novel analogs of the present invention, when refolded, have substantially the same biological activity as naturally occurring PDGF B109. The method of the present invention employs the use of a stop codon on the c-sis gene, or other coding sequence for a precursor protein of PDGF B109, or analogs thereof, at a position corresponding to a location from about amino acid 111 to about amino acid 160. The method of the present invention results in the production of relatively large homogeneous quantities of recombinant PDGF B analogs from high expression host cells, such as E. coli.
Patent AU-7331996-A (AU)
Title: Composition and method of imparting resistivity to hiv superinfection to cells
Inventor: FEDERICO MAURIZIO
IPC: A61K48/00
Filed: 1996-10-08
Abstract: The invention describes the expression of a human immunodeficiency virus (HIV) type 1 provirus (F12-HIV) cloned from a nonproducer, chronically-infected CD4 down-regulated Hut-78 cell clone (F12) which does not lead to the formation of viral particles and, upon transfection in HeLa CD4+ cells, confers resistance to HIV superinfection without affecting CD4 receptor exposure. A Moloney murine leukemia virus-based retroviral vector containing an F12-HIV genome lacking the 3' long terminal repeat (LTR) and part of the nef gene, expressed under the control of its 5' LTR, was constructed to facilitate the transfer of the anti-HIV properties of F12-HIV into human cells. The F12-HIV genome was inserted in an orientation opposite to that of the murine leukemia virus transcriptional unit and was designated the N2/F12-HIV nef- antisense vector. Lymphoblastoid CEMss cells, as well as human peripheral blood lymphocytes, were successfully transduced by the recombinant retrovirus. CEMss clones expressing the F12-HIV nef- antisense vector were resistant to HIV superinfection even at the highest multiplicity of infection tested (105 50% tissue culture infective doses per 106 cells). Nonproducer, interfering HIV proviruses transduced into retroviral vectors may provide an alternative strategy for the protection of CD4+ human primary cells from HIV infection.
Patent AU-7439594-A (AU)
Title: Corticoid 17,21-dicarboxylic esters and cortiscosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds
Inventor: STACHE ULRICH
IPC: A61K31/56
Filed: 1994-10-03
Abstract: Corticoid 17,21-dicarboxylic esters and corticoid 17-carboxylic esters 21-carbonic esters of the formula I <IMAGE>  with     A equal to CHOH and CHClm CH2, C=0, 9(11) double bond;   Y equal to H, F, Cl;   Z equal to H, F, methyl,   R(1) equal to aryl, hetaryl;   R(2) equal to alkyl,   R(3) equal to H, methyl are described. They are obtained, inter alia, by reacting a compound of the formula II <IMAGE> in which R(5) is equal to OH, with an activated carboxylic acid of the formula III <IMAGE>   They have very high local and topical antiinflammatory activity and show a very good ratio of local to systemic antiinflammatory effect. They are used inter alia as agents for treating inflammatory dermatoses.
Patent AU-7502991-A (AU)
Title: Process for the preparation of an ethylene copolymer and an olefin polymer, and catalysts for olefin polymerization
Inventor: TSUTSUI TOSHIYUKI
IPC: C08F2/14
Filed: 1991-04-16
Abstract: The present invention provides an ethylene copolymer comprising constituent units (a) derived from ethylene and constituent units (b) derived from an  alpha -olefin having 3 to 20 carbon atoms, the ethylene copolymer being characterized in that   (A) the ethylene copolymer has a density (d) of 0.86 to 0.95 g/cm<3>;   (B) the ethylene copolymer has a MFR of 0.001 to 50 g/10 min as measured at a temperature of 190 DEG C and a load of 2.16 kg; (C) the melt tension (MT) and MFR of the ethylene copolymer satisfy the relation    log MT > -0.66log MFR + 0.6; and     (D) the temperature (T) at which the exothermic curve of the ethylene copolymer measured by a differential scanning calorimeter (DSC) shows the highest peak and the density (d) satisfy the relation    T < 400d - 250. t
Patent AU-7530900-A (AU)
Title: Method and architecture for remote monitoring of a user station via an internet-type network and application thereof to a smart card demonstrator
Inventor: MARIANA RENAUD
IPC: G06F15/00
Filed: 2000-09-25
Abstract: The invention concerns a method and an architecture using a smart card ( 2 ) for remote control, via an internet-type network (RI), of a user station ( 1 ) comprising a smart card reader ( 3 ). The data required to control the station ( 1 ) are stored ( 41 ) in a remote server ( 4 ). The station ( 1 ) comprises a web-type browser ( 10 ) that transmits requests to the server ( 4 ). In response, the latter generates specific commands designed for the smart card ( 2 ). The station ( 1 ) comprises a specialized software module ( 8 ) forming an interface between the smart card reader ( 3 ) and the internet network (RI). This module ( 8 ) translates the specific commands into commands in conformity with the ISO 7816-4 standard, and transmits them to the smart card ( 2 ) in order to activate an application of the latter. The server ( 4 ) can also store ( 42 ) HTML pages. The smart card ( 2 ) transmits, via the specialized software module ( 8 ), a response to the remote server ( 4 ), which processes it and retransmits the data to the browser ( 10 ) for display on a screen ( 5 ). The invention is particularly applicable to a smart card ( 2 ) demonstrator.
Patent AU-7542100-A (AU)
Title: Building structure framework for protecting stage structure
Inventor: WEMYSS GEORGE ANDREW
IPC: E04H15/18
Filed: 2000-10-04
Abstract: A building structure framework for supporting a sheet material covering comprises a main structure (A) having a generally rectangular floor plan and being constituted by a plurality of generally parallel arches (1) which extend at right-angles to an axis of symmetry of the floor plan. Each arch (1) is constituted by a plurality of interconnected girders (4, 5, 6) comprising a pair of leg girders (4) for supporting the arch on a horizontal surface, and at least four identical main girders (5).
Patent AU-7566496-A (AU)
Title: Control device for a diesel-operated internal-combustion engine and oil-heating system
Inventor: GEHLING JOHANNES
IPC: F02B1/12
Filed: 1996-09-18
Abstract: A control system for a diesel-operating internal combustion engine has in a cast-plastic housing heater connected to the air supply line and upstream of an air mixer and an adjusting device in the diesel fuel line leading to the mixer. A limiter is provided between an air control device in the air supply line and the mixer can include a cylindrical gate around which the air is guided and an air control plunger at the upstream end of that body.
Patent AU-7876991-A (AU)
Title: Method and apparatus for timing recovery in digital data communications systems
Inventor: CAPKUN EDWARD ANTHONY
IPC: H04L7/04
Filed: 1991-05-23
Abstract: In apparatus for receiving digital data signals in a digital communication system, especially an Integrated Services Digital Network, timing recovery problems associated with erratic zero crossing when multiple terminals transmit to a common receiver are mitigated by detecting the rate of change of the digital data signal between two predetermined positions and controlling sampling of the digital data signal in dependence upon the difference between such rate of change and a reference. The rate of change conveniently corresponds to the trailing "corner" of a framing pulse, i.e. the point at which the signal commences the transition from one polarity to the other. The "corner" is much more stable, i.e. less susceptible to variation due to multiple terminal effects, than the zero-crossing which follows it, since the zero crossing may vary relative to the "corner". The transition may be determined by sampling the digital data signal at two discrete positions and determining when the two resulting samples differ in amplitude by a predetermined amount. One of the two pulses, namely the one with the larger amplitude, may then be used for data recovery purposes.
Patent AU-8116301-A (AU)
Title: Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
Inventor: MOHLER KENDALL M
IPC: A61P17/02
Filed: 2001-08-06
Abstract: The invention provides methods of treating autoimmune and chronic inflammatory conditions by administering agents that hinder the CD30/CD30L interaction, combination treatments, and methods of treating conditions resistant to treatment with TNFα inhibitors by administering agents that inhibit signal transduction by CD30 or IL-1. Included also are treatments involving concurrently administering agents that block the CD30/CD30L interaction and agents that antagonize the IL-4/IL-4R interaction. Additionally provided is an animal model for screening candidate agents for their efficacy in treating conditions that are resistant to treatment with TNFα inhibitors.
Patent AU-8754398-A (AU)
Title: An indicating device, specially in a vehicle
Inventor: ADELSSON PER
IPC: G01D7/00
Filed: 1998-08-11
Abstract: An indicating device in a vehicle that supplies complementary information to the driver of the vehicle. The device is provided with at least one scale for displaying basic information on an index disc. The index disc includes indicators arranged in close connection with and in relation to individual indexes of the scale and arranged as individually controllable light sources for indicating complementary information, which is relatable to the scale. The scale is arranged so that the basic information includes the vehicle speed and the complementary information of a relative speed to a vehicle in front.
Patent AU-8758601-A (AU)
Title: Roof covering
Inventor: WEBER HUGO
IPC: E04D3/40
Filed: 2001-07-06
Abstract: The invention relates to a roof covering for cleaning and keeping the roofs of buildings clean, in particular of plant growth, or pollutants, comprising a sheet-like material (1) which reacts in co-operation with moisture. The sheet-like material forms a partly closed chamber, when in the state of being set upon an inferior roof element (5) and slowly releases the moisture accumulated in said chamber to the exterior.
Patent AU-8899782-A (AU)
Title: Interesterification process and apparatus
IPC: C11C3/10
Filed: 1982-10-04
Abstract: The process is a continuous process and comprises bringing together streams comprising a triglyceride oil and a catalyst solution of water, sodium hydroxide and glycerine respectively, homogenizing the mixture, reducing its water content, and interesterifying. Preferably the homogenization and drying steps take place consecutively and are combined and are performed by passage through a spray drying nozzle. The efficiency of the homogenization and drying steps allows the interesterifying step to take place in about 4 minutes and thus permit operation of the process in a continuous manner.
Patent AU-9073591-A (AU)
Title: Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth)
Inventor: RECKER ROBERT R
IPC: A61P5/12
Filed: 1991-11-01
Abstract: A method of treating osteoporosis, especially postmenopausal osteoporosis, by administering on a periodic but regular basis to a patient growth hormone releasing factor, GRF(1-44)-NH2, or a biologically active analog thereof, and concurrently administering parathyroid hormone, PTH(1-34)-NH2 and continuing the administration until bone mass increases and the patient's calcium balance becomes positive and indicates a mineral accumulation in the skeleton.
Patent AU-9095698-A (AU)
Title: Method for bleaching discolored tooth by titanium dioxide photocatalyst
Inventor: ISHIBASHI TAKURO
IPC: A61Q11/00
Filed: 1998-09-18
Abstract: The present invention relates to a method for bleaching a discolored tooth, comprising the steps of applying a solution/paste of titanium dioxide powder and hydrogen peroxide solution onto the surface of discolored teeth, and bleaching the tooth based on the photocatalytic action that is produced by irradiating this area with light; and to a bleaching agent for applying onto the surface of discolored tooth to bleach the discolored tooth based on the photocatalytic action that is produced by irradiating this area with light, the bleaching agent comprising as active ingredients a combination of hydrogen peroxide solution and titanium dioxide producing photocatalytic action when irradiated with light.
Patent AU-9172298-A (AU)
Title: Gasket for cladding system
Inventor: REYNOLDS DONALD ARTHUR
IPC: E06B3/96
Filed: 1998-09-16
Abstract: A method of forming a joint ( 32 ) between two plastics extrusions ( 10 ) is disclosed which comprises mitring the extrusions ( 10 ) so that they form the desired angle to one another, removing part of the rear face of each extrusion ( 10 ) placing the mitred extrusions in a mould and injecting a resin material whereby to bond the extrusions ( 10 ) to one another and produce the desired joint ( 32 ) configuration. Because the front surface ( 24 ) of the joint in accordance with the invention is entirely made up from the original extrusion, there are no problems with raised sight-lines, colour differentials, surface differences, or colour matching. Moreover, the method of the invention allows a corner to be produced which has a clean right angled rather than radiused inner portion.